|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 |
| (11) | Patento numeris | 2443252 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10725045.8 |
| Europos patento paraiškos padavimo data | 2010-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/003563 |
| Data | 2010-06-15 |
| (87) | Numeris | WO 2010/145796 |
| Data | 2010-12-23 |
| (30) | Numeris | Data | Šalis |
| 09008042 | 2009-06-19 | EP | |
| 09012197 | 2009-09-25 | EP |
| (72) |
STROH, Christopher, DE
VON HEYDEBRECK, Anja, DE
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY |
| BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY |